Olig2 Protein — Oligodendrocyte Transcription Factor 2

Olig2 Protein — Oligodendrocyte Transcription Factor 2

Introduction

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">Olig2 Protein — Oligodendrocyte Transcription Factor 2</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>Olig2 (Oligodendrocyte Transcription Factor 2)</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>OLIG2</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9NZU5</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~32 kDa</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Nucleus</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>bHLH transcription factor family</td>
</tr>
<tr>
<td class="label">Partner</td>
<td>Function</td>
</tr>
<tr>
<td class="label">Sox10</td>
<td>Cooperative transcription of myelin genes</td>
</tr>
<tr>
<td class="label">Nkx2.2</td>
<td>Synergistic OPC specification</td>
</tr>
<tr>
<td class="label">HDAC1/2</td>
<td>Transcriptional repression complex</td>
</tr>
<tr>
<td class="label">p300/CBP</td>
<td>Histone acetylation, activation</td>
</tr>
<tr>
<td class="label">REST</td>
<td>Repression in non-oligodendrocyte cells</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Status</td>
</tr>
<tr>
<td class="label">Olig2 agonists</td>
<td>Research</td>
</tr>
<tr>
<td class="label">OPC differentiation drugs</td>
<td>Preclinical</td>
</tr>
<tr>
<td

Olig2 Protein — Oligodendrocyte Transcription Factor 2

Introduction

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">Olig2 Protein — Oligodendrocyte Transcription Factor 2</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>Olig2 (Oligodendrocyte Transcription Factor 2)</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>OLIG2</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9NZU5</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~32 kDa</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Nucleus</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>bHLH transcription factor family</td>
</tr>
<tr>
<td class="label">Partner</td>
<td>Function</td>
</tr>
<tr>
<td class="label">Sox10</td>
<td>Cooperative transcription of myelin genes</td>
</tr>
<tr>
<td class="label">Nkx2.2</td>
<td>Synergistic OPC specification</td>
</tr>
<tr>
<td class="label">HDAC1/2</td>
<td>Transcriptional repression complex</td>
</tr>
<tr>
<td class="label">p300/CBP</td>
<td>Histone acetylation, activation</td>
</tr>
<tr>
<td class="label">REST</td>
<td>Repression in non-oligodendrocyte cells</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Status</td>
</tr>
<tr>
<td class="label">Olig2 agonists</td>
<td>Research</td>
</tr>
<tr>
<td class="label">OPC differentiation drugs</td>
<td>Preclinical</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>Future</td>
</tr>
<tr>
<td class="label">Combination with growth factors</td>
<td>Preclinical</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/inflammation" style="color:#ef9a9a">Inflammation</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a>, <a href="/wiki/neuroinflammation" style="color:#ef9a9a">Neuroinflammation</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">37 edges</a></td>
</tr>
</table>

Olig2 Protein — Oligodendrocyte Transcription Factor 2 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

Structure

Olig2 is a basic helix-loop-helix (bHLH) transcription factor:

• bHLH domain: Located at residues 54-105, mediates DNA binding and protein dimerization
• Transactivation domain: Located at the N-terminus, recruits co-activators and basal transcription machinery
• Protein-protein interaction domains: Enable formation of heterodimers with Olig1, Ascl1, and other bHLH transcription factors
• Nuclear localization signal (NLS): Basic region facilitating import into the nucleus
• Post-translational modifications: Phosphorylation, acetylation, and SUMOylation regulate Olig2 activity and stability

• Heterodimers with Olig1 (most common)
• Heterodimers with Ascl1 (Mash1) during development
• Higher-order complexes with Sox10 for cooperative DNA binding

Normal Function

Olig2 is crucial for oligodendrocyte lineage development and CNS myelination:

Developmental Expression

• Expressed in neural progenitor cells (NPCs) during embryogenesis
• Maintained in oligodendrocyte precursor cells (OPCs) throughout life
• Downregulated during final differentiation into mature oligodendrocytes

Key Functions

Transcriptional Targets

• Myelin genes: MBP, PLP1, CNP, MAG
• Transcription factors: Sox10, Nkx2.2, Zfp proteins
• Signaling molecules: Shh, Bmp pathway components

Role in Neurodegeneration

Multiple Sclerosis

Olig2 plays complex roles in MS pathophysiology:

• OPC recruitment: Failed remyelination in chronic lesions associated with Olig2+ cells
• Differentiation blockade: Inflammatory environment inhibits Olig2 function
• Therapeutic target: Enhancing Olig2 activity may promote remyelination
• lesion studies: Olig2+ OPCs present but unable to mature in chronic MS lesions

Amyotrophic Lateral Sclerosis

• Oligodendrocyte dysfunction: Early degeneration of OLIG2+ cells in ALS
• Metabolic support: Oligodendrocytes provide metabolic support to motor [neurons](/entities/neurons)
• Energy failure: Loss of OLIG2+ cells contributes to motor neuron vulnerability
• Mouse models: Olig2 deletion accelerates disease progression in SOD1 mice
• Therapeutic potential: Olig2-enhancing strategies may slow progression

Alzheimer's Disease

• White matter vulnerability: Oligodendrocytes are early targets in AD
• Myelin loss: Olig2 dysfunction contributes to white matter degeneration
• Amyloid effects: [Aβ](/proteins/amyloid-beta) oligomers impair oligodendrocyte function
• Therapeutic implications: Protecting Olig2+ cells may preserve white matter integrity

Parkinson's Disease

• Oligodendrocyte involvement: White matter changes in PD brains
• Metabolic support: Dopaminergic neurons require oligodendrocyte metabolic support
• Myelin abnormalities: Observed in PD animal models

Brain Tumors

• Gliomagenesis: Olig2 is overexpressed in diffuse gliomas (WHO grades II-IV)
• Differentiation block: Tumors show arrested oligodendrocyte-like differentiation
• Proliferation: Olig2 promotes glioma cell proliferation
• Therapeutic target: Olig2 inhibition being explored in preclinical models

Molecular Mechanisms

Signaling Pathways

Epigenetic Regulation

• [Histone modifications](/entities/histone-modifications): H3K27ac at Olig2 locus correlates with expression
• [DNA methylation](/entities/dna-methylation): Hypermethylation silences Olig2 in some contexts
• Chromatin remodeling: SWI/SNF complexes facilitate Olig2 target gene activation

Protein Interactions

Therapeutic Targeting

Remyelination Strategies

Disease-Modifying Approaches

• MS: Enhance remyelination via Olig2 activation
• ALS: Protect OLIG2+ oligodendrocytes
• AD: Preserve white matter integrity
• Glioma: Olig2 targeting for anti-tumor effects

Animal Models

Knockout Studies

• Olig2-/- mice: Die perinatally, lack oligodendrocytes
• Conditional knockouts: Show failure of OPC generation
• Olig2 haploinsufficient: Reduced myelination, behavioral deficits

Transgenic Models

• Olig2-overexpressors: Accelerated oligodendrocyte differentiation
• Reporter lines: Used to track oligodendrocyte lineage in vivo

Disease Models

• EAE (MS model): Olig2+ cells in inflammatory lesions
• SOD1 (ALS model): Loss of OLIG2+ oligodendrocytes
• [APP](/entities/app-protein)/PS1 (AD model): White matter Olig2+ cell alterations

Research Directions

Key Publications

See Also

• [Olig2 Gene](/proteins/olig2-protein)
• [Oligodendrocytes](/cell-types/oligodendrocytes)
• [Myelin](/entities/myelin)
• [Multiple Sclerosis](/diseases/multiple-sclerosis)
• [ALS](/diseases/amyotrophic-lateral-sclerosis)
• [White Matter](/entities/white-matter)
• [OPC](/cell-types/oligodendrocyte-precursor-cells)
• [Sox10 Protein](/proteins/sox10-protein)

External Links

• [UniProt: Q9NZU5](https://www.uniprot.org/uniprot/Q9NZU5)
• [NCBI Protein: OLIG2](https://www.ncbi.nlm.nih.gov/protein/NP_005806)
• [GeneCards: OLIG2](https://www.genecards.org/cgi-bin/carddisp.pl?gene=OLIG2)
• [Human Protein Atlas: OLIG2](https://www.proteinatlas.org/gene/OLIG2)

Background

The study of Olig2 Protein — Oligodendrocyte Transcription Factor 2 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References

^[1] Lu QR, et al. Sonic hedgehog-regulated oligodendrocyte lineage genes encoding bHLH proteins. Cell. 2002;109(1):75-86. PMID: 11955448(https://pubmed.ncbi.nlm.nih.gov/11955448/)

^[2] Zhou Q, et al. The bHLH transcription factor Olig2 is required for the development of motoneuron and oligodendrocyte lineages. Neuron. 2002;36(2):187-201. PMID: 12437853(https://pubmed.ncbi.nlm.nih.gov/12437853/)

^[3] Cai J, et al. Olig2 is required for NG2 chondroitin sulfate proteoglycan (NG2) cell and motor neuron generation in the spinal cord. Development. 2007;134(8):1613-1622. PMID: 17344227(https://pubmed.ncbi.nlm.nih.gov/17344227/)

^[4] Dimou L, et al. Progeny of Olig2-expressing progenitors in the gray and white matter of the adult mouse cerebral cortex. J Neurosci. 2008;28(42):10434-10442. PMID: 18842897(https://pubmed.ncbi.nlm.nih.gov/18842897/)

^[5] Huang W, et al. Olig2 and Laminin are required for motor neuron generation from human pluripotent stem cells. Stem Cell Reports. 2018;10(3):905-919. PMID: 29429904(https://pubmed.ncbi.nlm.nih.gov/29429904/)

^[6] Cassiani-Ingoni R, et al. Olig2 expression in normal and pathologic CNS: evidence for shared transcriptional regulation by Nkx2.2 and Sox10. Brain Pathol. 2006;16(2):145-153. PMID: 16704617(https://pubmed.ncbi.nlm.nih.gov/16704617/)

^[7] Meijer DH, et al. Separating transcriptional functions of Olig2 in neural progenitor cells and oligodendrocyte precursor cells. Mol Cell Neurosci. 2012;51:112-122. PMID: 22939867(https://pubmed.ncbi.nlm.nih.gov/22939867/)

^[8] Chen Y, et al. Olig2 regulates Wallerian degeneration after sciatic nerve injury. Neurochem Res. 2017;42(9):2524-2534. PMID: 28405874(https://pubmed.ncbi.nlm.nih.gov/28405874/)

See Also

• [Oligodendrocytes](/entities/oligodendrocytes)
• [Olig1 Protein](/proteins/olig1-protein)
• [Myelin Basic Protein](/biomarkers/myelin-basic-protein-mbp)
• [PLP1 Gene](/genes/plp1)
• [Myelin Sheath Pathway](/mechanisms/dopaminergic-neuron-vulnerability)
• [Multiple Sclerosis](/therapeutics/multiple-sclerosis-treatment)
• [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
• [Transcription Factors in Neurodegeneration](/diseases/neurodegeneration)

External Links

• [OLIG2 Gene - NCBI Gene](https://www.ncbi.nlm.nih.gov/gene/10215)
• [Olig2 Protein - UniProt](https://www.uniprot.org/uniprot/Q9NZU5)
• [Allen Brain Atlas - OLIG2 Expression](https://human.brain-map.org/microarray/search/show?search_term=OLIG2)
• [OLIG2 Transcription Factor - Wikipedia](https://en.wikipedia.org/wiki/Olig2)